RecruitingNot ApplicableNCT06888804

Posterior Tibial Nerve PRF for Painful Calcaneal Fracture

Evaluation of the Effectiveness of Pulsed Radiofrequency Treatment of the Posterior Tibial Nerve in the Management of Chronic Plantar Pain Due to Calcaneal Fracture


Sponsor

Diskapi Teaching and Research Hospital

Enrollment

50 participants

Start Date

Mar 17, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Patients who underwent pulsed radiofrequency (PRF) treatment of the posterior tibial nerve under ultrasound guidance, which is routinely performed in our clinic for severe heel pain following a calcaneal fracture, were evaluated through interviews. The assessment was conducted using the Visual Analog Scale (VAS) for pain and the American Orthopaedic Foot and Ankle Society (AOFAS) score.


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Inclusion Criteria3

  • History of calcaneal fracture
  • VAS score >5
  • Pain persisting for more than 3 months after the fracture

Exclusion Criteria5

  • Presence of other foot pain-causing conditions (e.g., plantar fasciitis, heel spur)
  • Additional fractures other than the calcaneus
  • Pregnancy
  • Coagulopathy or use of antiplatelet medications
  • Mental illness impairing decision-making ability

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREultrasound-guided posterior tibial nerve pulsed radiofrequency

The posterior tibial nerve (PTN) was identified with a 5-12 MHz linear ultrasonography (US) probe at the level of the medial malleolus, where it runs posterior to the posterior tibial artery. Using the in-plane technique, a 22-gauge, 10-cm radiofrequency cannula was inserted under US guidance and advanced until the tip was adjacent to the nerve. Pulse radiofrequency was applied at 42°C for 240 s with a pulse width of 20 ms.

OTHERControl Group

No intervention


Locations(1)

Diskapi Training and Research Hospital

Ankara, Turkey (Türkiye)

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06888804


Related Trials